Literature DB >> 17934820

Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.

Rocio Aller1, Daniel A de Luis, Luis Fernandez, Fernando Calle, Benito Velayos, Jose Luis Olcoz, Olatz Izaola, Manuel Gonzalez Sagrado, Rosa Conde, Jose Manuel Gonzalez.   

Abstract

The objective of this work was to study the influence of insulin resistance and adipokines on the grade of steatosis in patients with NAFLD (nonalcoholic fatty liver disease) diagnosed by liver biopsy. A sample of 24 NAFLD patients was analyzed in a cross-sectional study. All patients with a two-week weight-stabilization period before recruitment were enrolled. A liver biopsy was realized. Weight, basal glucose, insulin, insulin resistance (HOMA), total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and adipokines blood levels were measured. A nutritional evaluation (dietary intake, indirect calorimetry, and bioimpedance) was performed. The mean age was 41.6 +/- 8.7 years and the mean body mass index (BMI) 29.4 +/- 4.7. Twelve patients had a low grade of steatosis (grade 1 of the Brunt classification) and 12 patients had a high grade of steatosis (grade 2 or 3). Only HOMA was higher in patients with a high grade of steatosis (1.4 +/- 0.5 vs. 2.8 +/- 1.7 units; P < 0.05). Anthropometric data and dietary intake were similar for both groups. Blood levels of adiponectin were higher in patients with a low grade of steatosis (37.7 +/- 22.5 vs. 24.2 +/- 33 ng mL(-1); P < 0.05). Blood levels of resistin were higher in patients with a high grade of steatosis (2.36 +/- 0.6 vs. 2.8 +/- 0.6 mg mL(-1); P < 0.05), without differences in TNF-alpha or leptin levels. In logistic regression analysis, the HOMA-IR remained in the model, with an odds ratio to develop high grade of steatosis of 7.8 (95% CI: 1.8-75) with each 1 unit of HOMA-IR adjusted by age, sex, BMI, and dietary intake. This study demonstrates that insulin resistance determined with the HOMA model is associated with a high grade of steatosis in patients with NAFLD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934820     DOI: 10.1007/s10620-007-9981-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

Review 1.  Adipocytokines: emerging therapeutic targets.

Authors:  Yuji Matsuzawa
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

2.  Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis. The Italian Hemodialysis-Bioelectrical Impedance Analysis (HD-BIA) Study Group.

Authors:  A Piccoli
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

3.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Authors:  Shivakumar Chitturi; Shehan Abeygunasekera; Geoffrey C Farrell; Jane Holmes-Walker; Jason M Hui; Caroline Fung; Rooshdiya Karim; Rita Lin; Dev Samarasinghe; Christopher Liddle; Martin Weltman; Jacob George
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

4.  The hormone resistin links obesity to diabetes.

Authors:  C M Steppan; S T Bailey; S Bhat; E J Brown; R R Banerjee; C M Wright; H R Patel; R S Ahima; M A Lazar
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

Review 5.  Nonalcoholic steatohepatitis: definition and pathology.

Authors:  E M Brunt
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

6.  Liver pathology and the metabolic syndrome X in severe obesity.

Authors:  P Marceau; S Biron; F S Hould; S Marceau; S Simard; S N Thung; J G Kral
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

7.  Circulating adiponectin and plasma fatty acid profile.

Authors:  José-Manuel Fernández-Real; Joan Vendrell; Wifredo Ricart
Journal:  Clin Chem       Date:  2005-01-06       Impact factor: 8.327

8.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

Authors:  I Shimomura; R E Hammer; S Ikemoto; M S Brown; J L Goldstein
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

9.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

10.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

View more
  15 in total

Review 1.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

2.  Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease.

Authors:  Raika Jamali; Mohsen Razavizade; Abbas Arj; Mohammad Hossein Aarabi
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

3.  Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.

Authors:  Rafael Bergesch D'Incao; Cristiane Valle Tovo; Vanessa Suñé Mattevi; Diego Olschowsky Borges; Jane Maria Ulbrich; Gabriela Perdomo Coral; Mauricio Jacques Ramos; Nelson Guardiola Meinhardt
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

4.  Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans.

Authors:  Dae Hee Choi; Sung Joon Lee; Chang Don Kang; Myoung Ok Park; Dong Wook Choi; Tae Suk Kim; Wonho Lee; Byung Ryul Cho; Yong Hoon Kim; Bong-ki Lee; Dong Ryeol Ryu; Ji Won Lee
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

5.  Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.

Authors:  Marianna Argentou; Dina G Tiniakos; Menelaos Karanikolas; Maria Melachrinou; Maria G Makri; Christos Kittas; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2009-07-15       Impact factor: 4.129

Review 6.  The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease.

Authors:  C Boutari; K Tziomalos; V G Athyros
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

7.  Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).

Authors:  Daniela Catalano; Giuseppe Fabio Martines; Antonia Tonzuso; Clara Pirri; Francesca M Trovato; Guglielmo M Trovato
Journal:  Dig Dis Sci       Date:  2010-02-18       Impact factor: 3.199

Review 8.  Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.

Authors:  Hyunmi Kim; Da Som Lee; Tae Hyeon An; Hyun-Ju Park; Won Kon Kim; Kwang-Hee Bae; Kyoung-Jin Oh
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

9.  Chronic administration of Angelica sinensis polysaccharide effectively improves fatty liver and glucose homeostasis in high-fat diet-fed mice.

Authors:  Kaiping Wang; Peng Cao; Hanxiang Wang; Zhuohong Tang; Na Wang; Jinglin Wang; Yu Zhang
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

10.  Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.

Authors:  Raika Jamali; Abbas Arj; Mohsen Razavizade; Mohammad Hossein Aarabi
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.